Shares of Clorox Co. (NYSE:CLX) have been assigned a consensus rating of “Hold” from the twelve ratings firms that are presently covering the stock. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $128.90.
Several equities research analysts recently issued reports on CLX shares. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research note on Monday, August 8th. Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research note on Friday, September 16th. Jefferies Group reiterated a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Deutsche Bank AG reiterated a “hold” rating and issued a $134.00 price target (up from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Finally, B. Riley reiterated a “neutral” rating and issued a $109.00 price target on shares of Clorox in a research note on Tuesday, August 9th.
Clorox (NYSE:CLX) opened at 125.18 on Monday. The company has a market cap of $16.21 billion, a PE ratio of 25.44 and a beta of 0.33. The stock has a 50 day moving average price of $127.93 and a 200 day moving average price of $130.05. Clorox has a 1-year low of $117.08 and a 1-year high of $140.47.
Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.28 by $0.02. The company earned $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.44 earnings per share. Equities analysts forecast that Clorox will post $5.49 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.56%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s payout ratio is 64.91%.
In other news, EVP Laura Stein sold 38,882 shares of the stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the transaction, the executive vice president now directly owns 48,501 shares in the company, valued at approximately $6,387,096.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Nikolaos A. Vlahos sold 925 shares of the stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The disclosure for this sale can be found here. 2.09% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Invictus RG bought a new stake in Clorox during the first quarter worth $110,000. Checchi Capital Advisers LLC increased its stake in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the last quarter. Feltz Wealth PLAN Inc. bought a new stake in Clorox during the second quarter worth $114,000. Valley National Advisers Inc. increased its stake in Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 845 shares of the company’s stock worth $117,000 after buying an additional 5 shares during the last quarter. Finally, Blue Chip Partners Inc. increased its stake in Clorox by 7.1% in the second quarter. Blue Chip Partners Inc. now owns 890 shares of the company’s stock worth $123,000 after buying an additional 59 shares during the last quarter. Institutional investors own 70.27% of the company’s stock.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.